http://www.zibb.com/all/theme/cq/Savient+Pharmaceuticals+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Wed, 04 Nov 2009 15:23:46 GMTWed, 04 Nov 2009 15:23:46 GMT608831http://www.zibb.com/all/theme/cq/Savient+Pharmaceuticals+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.bio-medicine.org/medicine-technology-1/Savient-Pharmaceuticals-Reports-Third-Quarter-2009-Financial-Results-6000-1/...EAST BRUNSWICK N.J. Nov. 4 /- Savient Pharmac... Our strengthened cash position will support future important initiati... Operational Key Events: During July 2009 we c...,Savient,Pharmaceuticals,Reports,Third,Quarter,2009,Financial,Results,medicine,advanced medical technology,medical laboratoryhttp://www.bio-medicine.org/medicine-technology-1/Savient-Pharmaceuticals-Reports-Third-Quarter-2009-Financial-Results-6000-1/Savient Pharmaceuticals IncorporatedWed, 04 Nov 2009 15:23:46 GMThttp://www.newratings.com/headlines/Savient-Pharmaceuticals-Inc-_US80517Q1004.htmlCopyright © 2002 - 2008 newratings.com GmbH | Legal | Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using StandardPoor's ComStock Inc. and others. Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.http://www.newratings.com/headlines/Savient-Pharmaceuticals-Inc-_US80517Q1004.htmlSavient Pharmaceuticals Incorporatedhttp://www.evaluatepharma.com/CoInfo/CoInfo-SVNT.htmEvaluatePharma provides historic and forecast sales from 1986 to 2010 for worldwide and US Rx (prescription drugs) and OTC drugs. EvaluatePharma analysts continuously update company models from SEC filings, annual reports, investor/analyst presentations, company press releases, FDA and USPTO.http://www.evaluatepharma.com/CoInfo/CoInfo-SVNT.htmSavient Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=45555Savient Pharmaceuticals thinks it has drug savvy. The company sold its global biologics manufacturing operations to private Swiss drugmaker Ferring to focus on new drug development. Those operations included Bio-Tropin, a growth hormone for children, and BioLon, a lubricant for ophthalmic surgery.http://www.pharmacychoice.com/News/article.cfm?Article_ID=45555Savient Pharmaceuticals Incorporatedhttp://www.pcquote.com/stocks/index.php?symbols=SVNTPowered by Money.net Business Solutions, the leading provider of professional-quality, customized market data and enterprise content solutions for investors, media companies, and financial institutions. For Sales Information Contact: (212) 334-2000.http://www.pcquote.com/stocks/index.php?symbols=SVNTSavient Pharmaceuticals Incorporatedhttp://www.mongabay.com/health/medications/Oxandrin.htmlThis page contains recent news articles, when available, and an overview of Oxandrin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.http://www.mongabay.com/health/medications/Oxandrin.htmlSavient Pharmaceuticals Incorporatedhttp://www.ferring.com/newsroom/archive/2005/btg.htmLausanne, Switzerland – July 19, 2005 – Ferring B.V. and Ferring International Centre SA announced today that they have completed the purchase of BTG (Biotechnology General), the global biologics manufacturing business of Savient Pharmaceuticals, Inc. (NASDAQ:SVNT).http://www.ferring.com/newsroom/archive/2005/btg.htmSavient Pharmaceuticals Incorporatedhttp://www.buyandhold.com/StockMgr?request=display.content&symbol=SVNT&ContentURL=%2Fcustom%2Fbuyandhold%2Dcom%2Fhtml%2Dnews%2Easp&symb=SVNTCopyright © 2007 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by ComStock, an Interactive Data Company and subject to the Terms of Use.http://www.buyandhold.com/StockMgr?request=display.content&symbol=SVNT&ContentURL=%2Fcustom%2Fbuyandhold%2Dcom%2Fhtml%2Dnews%2Easp&symb=SVNTSavient Pharmaceuticals Incorporatedhttp://www.holdrs.com/holdrs/main/index.asp?Action=Headlines&Description=&Image=TTH&symb=SVNTCopyright © 2009 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.http://www.holdrs.com/holdrs/main/index.asp?Action=Headlines&Description=&Image=TTH&symb=SVNTSavient Pharmaceuticals Incorporatedhttp://www.bio-medicine.org/medicine-news-1/Savient-Pharmaceuticals-Receives-Complete-Response-Letter-from-U-S--Food-and-Drug-Administration-for-KRYSTEXXA-28TM-29-53436-1/Health,... ... ... ...EAST BRUNSWICK N.J. Aug. 2 /- Savient Pharmac...,Savient,Pharmaceuticals,Receives,Complete,Response,Letter,from,U.S.,Food,and,Drug,Administration,for,KRYSTEXXA(TM),medicine,medical news today,latest medical news,medical newsletters,current medical news,latest medicine newshttp://www.bio-medicine.org/medicine-news-1/Savient-Pharmaceuticals-Receives-Complete-Response-Letter-from-U-S--Food-and-Drug-Administration-for-KRYSTEXXA-28TM-29-53436-1/Savient Pharmaceuticals IncorporatedSun, 02 Aug 2009 10:33:23 GMThttp://www.pharmacychoice.com/News/article.cfm?Article_ID=3781This trial was designed to test the safety and efficacy of Puricase in patients with symptomatic gout who are intolerant of or unresponsive to conventional therapy. The Company estimates approximately 35,000 to 50,000 patients in the United States. The U.S.http://www.pharmacychoice.com/News/article.cfm?Article_ID=3781Savient Pharmaceuticals Incorporatedhttp://www.bio-medicine.org/medicine-technology-1/Savient-Pharmaceuticals-Announces-Closing-of-Public-Offering-and-Exercise-of-Over-Allotment-Option-5511-1/...EAST BRUNSWICK N.J. Oct. 15 /- Savient Pharma...Savient intends to use the net proceeds from this offering to complete...J.P. Morgan Securities Inc. acted as sole book-running manager of the ...This press release does not constitute an offer to sell or thehttp://www.bio-medicine.org/medicine-technology-1/Savient-Pharmaceuticals-Announces-Closing-of-Public-Offering-and-Exercise-of-Over-Allotment-Option-5511-1/Savient Pharmaceuticals IncorporatedThu, 15 Oct 2009 16:09:05 GMThttp://www.pharmacychoice.com/News/article.cfm?Article_ID=43763Launch of Generic Oxandrolone Business Editors/Health/Medical Writers/Legal Writers EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Dec. 12, 2006--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) announced today that the United States Court of Appeals for the Federal Circuit in Washington, D.C.http://www.pharmacychoice.com/News/article.cfm?Article_ID=43763Savient Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=43122The TRO was granted in the lawsuit filed yesterday by Savient against Sandoz and Upsher-Smith in the U.S. District Court for the District of New Jersey for infringement of Savient's U.S. Patent Nos.http://www.pharmacychoice.com/News/article.cfm?Article_ID=43122Savient Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=42991Authorized Generic of Oxandrin(R) Business Editors/Health/Medical Writers EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Dec. 4, 2006--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that it has filed a lawsuit in the U.S.http://www.pharmacychoice.com/News/article.cfm?Article_ID=42991Savient Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=15631As previously announced, certain of those reported returns were in error and actual units of product returned were significantly less than the amounts originally expected to be returned.http://www.pharmacychoice.com/News/article.cfm?Article_ID=15631Savient Pharmaceuticals Incorporatedhttp://www.mongabay.com/health/medications/oxandrolone.htmlThis page contains recent news articles, when available, and an overview of oxandrolone but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.http://www.mongabay.com/health/medications/oxandrolone.htmlSavient Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=4390The primary objective of the study was to determine the most appropriate dosing for a pivotal Phase III clinical trial, upon which the registration will be based. The company believes that this objective has been achieved. The Phase II study was a randomised, open label, parallel design trial.http://www.pharmacychoice.com/News/article.cfm?Article_ID=4390Savient Pharmaceuticals Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=37128EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Sept. 26, 2006--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that it has filed a lawsuit in the U.S. District Court for the District of New Jersey against Barr Laboratories, Inc., a wholly-owned subsidiary of Barr Pharmaceuticals, Inc.http://www.pharmacychoice.com/News/article.cfm?Article_ID=37128Savient Pharmaceuticals Incorporatedhttp://www.holdrs.com/holdrs/main/index.asp?Action=Headlines&Description=&Image=&symb=SVNTCopyright © 2008 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.http://www.holdrs.com/holdrs/main/index.asp?Action=Headlines&Description=&Image=&symb=SVNTSavient Pharmaceuticals Incorporated